Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Y 24180

Known as: Y-24180 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
In human prostate cancer PC3 cells, the effect of Y-24180, a presumed specific platelet activation factor (PAF) receptor… Expand
Is this relevant?
2001
2001
To examine the effects of acid exposure on the adherence of Streptococcus pneumoniae to cultured human tracheal epithelial cells… Expand
Is this relevant?
1999
1999
Eosinophil activation and subsequent release of inflammatory mediators are implicated in the pathophysiology of allergic diseases… Expand
Is this relevant?
1999
1999
We examined the effects of Y-24180, a potent and long-acting antagonist to platelet-activating factor (PAF) receptor, on the… Expand
Is this relevant?
1998
1998
Abstract.Objective and Design: We examined the effect of Y-24180, a potent platelet-activating factor (PAF) antagonist, on IgE… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1997
1997
Abstract.Objective and Design: Effects of Y-24180 on antigen-induced asthmatic responses were evaluated in actively sensitized… Expand
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
1996
1996
Oxygen radicals produced by activated neutrophils have been involved in brain injury during ischemia-reperfusion. Platelet… Expand
Is this relevant?
1995
1995
The involvement of platelet-activating factor (PAF) in bronchial hyperresponsiveness (BHR) in bronchial asthma has been… Expand
Is this relevant?
1990
1990
The inhibitory effect of Y-24180, 4-(2-chlorophenyl)-2-[2-(4-isobutylphenyl)ethyl]-6,9-dimethyl-6H-t hieno [3,2-f][1,2,4]triazolo… Expand
Is this relevant?
1990
1990
The ability of Y-24180, 4-(2-chlorophenyl)-2-[2-(4-isobutylphenyl)ethyl]- 6,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a] [1… Expand
Is this relevant?